CAMBRIDGE, Massachusetts: Moderna on Thursday (Dec 31) confirmed it will supply 40 million doses of its COVID-19 vaccine to the South Korean government, with deliveries starting in May.
The vaccine, which is authorised for emergency use in the United States and Canada, is not currently approved in South Korea.
READ: South Korea moves COVID-19 patients out of nursing homes after spike in deaths
The company said it would work with regulators to pursue an approval prior to the distribution of the vaccine.
BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments
Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram